Sarepta Therapeutics, Inc. (SRPT)
17.50
-0.07
(-0.40%)
USD |
NASDAQ |
Oct 02, 16:00
17.50
0.00 (0.00%)
After-Hours: 20:00
Sarepta Therapeutics EPS Diluted (Quarterly) : -0.0464 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0464 |
| March 31, 2026 | 2.878 |
| December 31, 2025 | -3.934 |
| September 30, 2025 | -1.795 |
| June 30, 2025 | 1.887 |
| March 31, 2025 | -4.596 |
| December 31, 2024 | 1.612 |
| September 30, 2024 | 0.3387 |
| June 30, 2024 | 0.0683 |
| March 31, 2024 | 0.3644 |
| December 31, 2023 | 0.4324 |
| September 30, 2023 | -0.4605 |
| June 30, 2023 | -0.2698 |
| March 31, 2023 | -5.860 |
| December 31, 2022 | -1.244 |
| September 30, 2022 | -2.941 |
| June 30, 2022 | -2.645 |
| March 31, 2022 | -1.204 |
| December 31, 2021 | -1.419 |
| September 30, 2021 | -0.6027 |
| June 30, 2021 | -1.021 |
| March 31, 2021 | -2.105 |
| December 31, 2020 | -2.399 |
| September 30, 2020 | -2.503 |
| June 30, 2020 | -1.934 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.2289 |
| December 31, 2019 | -3.161 |
| September 30, 2019 | -1.703 |
| June 30, 2019 | -3.737 |
| March 31, 2019 | -1.068 |
| December 31, 2018 | -2.052 |
| September 30, 2018 | -1.15 |
| June 30, 2018 | -1.67 |
| March 31, 2018 | -0.55 |
| December 31, 2017 | -0.37 |
| September 30, 2017 | -0.78 |
| June 30, 2017 | -1.15 |
| March 31, 2017 | 1.50 |
| December 31, 2016 | -1.62 |
| September 30, 2016 | -1.18 |
| June 30, 2016 | -1.35 |
| March 31, 2016 | -1.31 |
| December 31, 2015 | -1.44 |
| September 30, 2015 | -1.25 |
| June 30, 2015 | -1.01 |
| March 31, 2015 | -1.49 |
| December 31, 2014 | -1.08 |
| September 30, 2014 | -0.71 |
| June 30, 2014 | -0.85 |
| March 31, 2014 | -0.75 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Moderna, Inc. | -1.965 |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Beam Therapeutics, Inc. | -1.176 |
| ImmunityBio, Inc. | -0.2194 |
| Twist Bioscience Corp. | -0.5617 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.89M |
| Revenue (Quarterly) | 401.25M |
| Total Expenses (Quarterly) | 406.14M |
| Enterprise Value | 2.106B |
| Gross Profit Margin (Quarterly) | 60.18% |
| Profit Margin (Quarterly) | -1.22% |
| Earnings Yield | -16.56% |
| Normalized Earnings Yield | -9.785 |